Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Help guide our efforts to modernize ClinicalTrials.gov.
Send us your comments by March 14, 2020.
Trial record 3 of 165 for:    Venetoclax AND overall

Venetoclax and Lintuzumab-Ac225 in AML Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03867682
Recruitment Status : Not yet recruiting
First Posted : March 8, 2019
Last Update Posted : November 29, 2019
Sponsor:
Information provided by (Responsible Party):
Actinium Pharmaceuticals

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Not yet recruiting
Estimated Primary Completion Date : November 2020
Estimated Study Completion Date : November 2022